Nanog acts as a therapeutic target of QYHJ in the treatment of pancreatic cancer stem cells, and its expression status mediates different responses to QYHJ treatment of pancreatic cancer stem cells. This evidence concerns the gene NANOG and familial pancreatic carcinoma.